Nonpeptide oxytocin agonists

被引:12
作者
Ashworth, Doreen M.
Batt, Andrzej R.
Baxter, Andrew J.
Broqua, Pierre
Haigh, Robert M.
Hudson, Peter
Heeney, Celine M. S.
Laporte, Regent
Penson, Andrew
Pitt, Gary R. W.
Robson, Peter A.
Rooker, David P.
Tartar, Andre L.
Yea, Chris M.
Roe, Michael B.
机构
[1] Ferring Res Ltd, Southampton SO16 7NP, Hants, England
[2] Ferring Pharmaceut AS, DK-2300 Copenhagen S, Denmark
[3] Ferring Res Inst Inc, San Diego, CA 92121 USA
[4] Fac Sci Pharmaceut & Biol, F-59006 Lille, France
关键词
D O I
10.1358/dof.2006.031.04.980655
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oxytocin is a neurohypophyseal hormone that acts at the oxytocin receptor localized both peripherally and centrally and is particularly highly expressed in the pregnant human myometrium. Synthetic oxytocin has long been used to induce labor and oxytocin antagonists have been introduced for the treatment of preterm labor. New compounds are described that are potent, selective and efficacious oxytocin receptor agonists with potential utility in promoting labor and for the treatment of conditions such as male and female sexual dysfunction. These new agents may also be useful as tools for further elucidating the roles of the oxytocin receptor system. Furthermore, as they are nonpeptidic in nature, they may offer advantages over peptide oxytocin analogues in terms of oral availability and central penetration. This article describes the various approaches that have been used to discover such compounds. Compounds such as 27, the first nonpeptide oxytocin agonists reported, are currently being investigated as pharmacological tools in animal models of oxytocin activity.
引用
收藏
页码:345 / 353
页数:9
相关论文
共 26 条
  • [21] Barusiban, a new highly potent and long-acting oxytocin antagonist: Pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor
    Reinheimer, TM
    Bee, WH
    Resendez, JC
    Meyer, JK
    Haluska, GJ
    Chellman, GJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) : 2275 - 2281
  • [22] Serradeil-Le Gal C, 2002, PROG BRAIN RES, V139, P197
  • [23] Vatish M, 2002, EXPERT OPIN THER PAT, V12, P1403
  • [24] Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency
    Williams, PD
    Bock, MG
    Evans, BE
    Freidinger, RM
    Gallicchio, SN
    Guidotti, MT
    Jacobson, MA
    Kuo, MS
    Levy, MR
    Lis, EV
    Michelson, SR
    Pawluczyk, JM
    Perlow, DS
    Pettibone, DJ
    Quigley, AG
    Reiss, DR
    Salvatore, C
    Stauffer, KJ
    Woyden, CJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (09) : 1311 - 1316
  • [25] Williams PD, 1996, CURR PHARM DESIGN, V2, P41
  • [26] Identification of potent and selective oxytocin antagonists. Part 1: Indole and benzofuran derivatives
    Wyatt, PG
    Allen, MJ
    Chilcott, J
    Foster, A
    Livermore, DG
    Mordaunt, JE
    Scicinski, J
    Woollard, PM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (10) : 1399 - 1404